- call +1-201-465-4211
- email sales@mrinsights.biz
Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.
Scope of the Report:
This report focuses on the Hypertension Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.
The worldwide market for Hypertension Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Lupin Limited
Novartis AG
Daiichi - Sankyo
Pfizer Inc
Ranbaxy Laboratories Limited
Sanofi S.A
AstraZeneca Plc
Johnson & Johnson Ltd
Boehringer Ingelheim
Merck & Co.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Market Segment by Applications, can be divided into
Hospital
Private clinic
Others
There are 15 Chapters to deeply display the global Hypertension Drug market.
Chapter 1, to describe Hypertension Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hypertension Drug, with sales, revenue, and price of Hypertension Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hypertension Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hypertension Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hypertension Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hypertension Drug Introduction
1.2 Market Analysis by Type
1.2.1 Calcium Channel Blockers
1.2.2 Diuretics
1.2.3 Beta Blockers Vasodilators
1.2.4 Angiotensin Converting Enzyme Inhibitors
1.2.5 Alpha Blockers
1.2.6 Angiotensin Receptor Blockers
1.2.7 Renin Inhibitors
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Private clinic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lupin Limited
2.1.1 Business Overview
2.1.2 Hypertension Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lupin Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Hypertension Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Daiichi - Sankyo
2.3.1 Business Overview
2.3.2 Hypertension Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Daiichi - Sankyo Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer Inc
2.4.1 Business Overview
2.4.2 Hypertension Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Inc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ranbaxy Laboratories Limited
2.5.1 Business Overview
2.5.2 Hypertension Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi S.A
2.6.1 Business Overview
2.6.2 Hypertension Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi S.A Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca Plc
2.7.1 Business Overview
2.7.2 Hypertension Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Plc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson Ltd
2.8.1 Business Overview
2.8.2 Hypertension Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Hypertension Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck & Co.
2.10.1 Business Overview
2.10.2 Hypertension Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck & Co. Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hypertension Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hypertension Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hypertension Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hypertension Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Hypertension Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Hypertension Drug Market Analysis by Regions
4.1 Global Hypertension Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Hypertension Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hypertension Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Hypertension Drug Sales and Growth Rate (2013-2018)
4.3 Europe Hypertension Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hypertension Drug Sales and Growth Rate (2013-2018)
4.5 South America Hypertension Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hypertension Drug Sales and Growth Rate (2013-2018)
5 North America Hypertension Drug by Countries
5.1 North America Hypertension Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Hypertension Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hypertension Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Hypertension Drug Sales and Growth Rate (2013-2018)
5.3 Canada Hypertension Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Hypertension Drug Sales and Growth Rate (2013-2018)
6 Europe Hypertension Drug by Countries
6.1 Europe Hypertension Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Hypertension Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hypertension Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hypertension Drug Sales and Growth Rate (2013-2018)
6.3 UK Hypertension Drug Sales and Growth Rate (2013-2018)
6.4 France Hypertension Drug Sales and Growth Rate (2013-2018)
6.5 Russia Hypertension Drug Sales and Growth Rate (2013-2018)
6.6 Italy Hypertension Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hypertension Drug by Countries
7.1 Asia-Pacific Hypertension Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hypertension Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hypertension Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Hypertension Drug Sales and Growth Rate (2013-2018)
7.3 Japan Hypertension Drug Sales and Growth Rate (2013-2018)
7.4 Korea Hypertension Drug Sales and Growth Rate (2013-2018)
7.5 India Hypertension Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hypertension Drug Sales and Growth Rate (2013-2018)
8 South America Hypertension Drug by Countries
8.1 South America Hypertension Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Hypertension Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hypertension Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hypertension Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Hypertension Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Hypertension Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hypertension Drug by Countries
9.1 Middle East and Africa Hypertension Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hypertension Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hypertension Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hypertension Drug Sales and Growth Rate (2013-2018)
9.3 UAE Hypertension Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Hypertension Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Hypertension Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Hypertension Drug Sales and Growth Rate (2013-2018)
10 Global Hypertension Drug Market Segment by Type
10.1 Global Hypertension Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hypertension Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Hypertension Drug Revenue and Market Share by Type (2013-2018)
10.2 Calcium Channel Blockers Sales Growth and Price
10.2.1 Global Calcium Channel Blockers Sales Growth (2013-2018)
10.2.2 Global Calcium Channel Blockers Price (2013-2018)
10.3 Diuretics Sales Growth and Price
10.3.1 Global Diuretics Sales Growth (2013-2018)
10.3.2 Global Diuretics Price (2013-2018)
10.4 Beta Blockers Vasodilators Sales Growth and Price
10.4.1 Global Beta Blockers Vasodilators Sales Growth (2013-2018)
10.4.2 Global Beta Blockers Vasodilators Price (2013-2018)
10.5 Angiotensin Converting Enzyme Inhibitors Sales Growth and Price
10.5.1 Global Angiotensin Converting Enzyme Inhibitors Sales Growth (2013-2018)
10.5.2 Global Angiotensin Converting Enzyme Inhibitors Price (2013-2018)
10.6 Alpha Blockers Sales Growth and Price
10.6.1 Global Alpha Blockers Sales Growth (2013-2018)
10.6.2 Global Alpha Blockers Price (2013-2018)
10.7 Angiotensin Receptor Blockers Sales Growth and Price
10.7.1 Global Angiotensin Receptor Blockers Sales Growth (2013-2018)
10.7.2 Global Angiotensin Receptor Blockers Price (2013-2018)
10.8 Renin Inhibitors Sales Growth and Price
10.8.1 Global Renin Inhibitors Sales Growth (2013-2018)
10.8.2 Global Renin Inhibitors Price (2013-2018)
11 Global Hypertension Drug Market Segment by Application
11.1 Global Hypertension Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Private clinic Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Hypertension Drug Market Forecast (2018-2023)
12.1 Global Hypertension Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Hypertension Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Hypertension Drug Market Forecast (2018-2023)
12.2.2 Europe Hypertension Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hypertension Drug Market Forecast (2018-2023)
12.2.4 South America Hypertension Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hypertension Drug Market Forecast (2018-2023)
12.3 Hypertension Drug Market Forecast by Type (2018-2023)
12.3.1 Global Hypertension Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Hypertension Drug Market Share Forecast by Type (2018-2023)
12.4 Hypertension Drug Market Forecast by Application (2018-2023)
12.4.1 Global Hypertension Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Hypertension Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hypertension Drug Picture
Table Product Specifications of Hypertension Drug
Figure Global Sales Market Share of Hypertension Drug by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
